Clinical trial · Interventional
Pilot Study of a Pharmacy Intervention for Older Adults With Cancer
NCT02871115CI-TRIAL-00055012completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this research study is to address the challenge of medication management for older patients undergoing treatment for cancer. The sponsor of this protocol is the Massachusetts General Hospital Cancer Center who is providing funding for this research study.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| GI Cancer | — | UNRESOLVED | — |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pharmacy Intervention | Other | — | UNRESOLVED |
| Usual Care | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Pharmacy Intervention
- description
- Patients randomized to the pharmacy intervention (PRIME) will undergo evaluation with a clinical pharmacist at their second or third chemotherapy infusion who will * Perform detailed medication reconciliation * Obtain allergy and vaccination history * Evaluate and document polypharmacy (number of medications) * Document their findings in the medical record and discuss their recommendations (in-person, phone call, email) with each patient's oncology team
- interventionNames
- Other: Pharmacy Intervention
- type
- ACTIVE_COMPARATOR
- label
- Usual Care
- description
- Participants receiving Usual Oncology Care will not meet with the pharmacist unless indicated as part of their routine clinical care * Study staff will obtain all patient-reported measures from the patient. * Remind participant to complete self-report measures
- interventionNames
- Other: Usual Care
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Age 65 or older * Diagnosed with any stage breast, GI or lung cancer * Panning to receive first-line chemotherapy at MGH * Verbal fluency in English Exclusion Criteria: * Unwilling or unable to participate in the study * Significant psychiatric, cognitive or other comorbid disease which the treating clinician believes prohibits informed consent or participation in the study
References
Publications (0)
Data not yet available
No reference posted for this study.